Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > Cagrilintide Suppresses appetite and enhances satiety
Cagrilintide Suppresses appetite and enhances satiety buy - large image1
Cagrilintide Suppresses appetite and enhances satiety buy - image1
Cagrilintide Suppresses appetite and enhances satiety buy - image2
Cagrilintide Suppresses appetite and enhances satiety buy - image3
Cagrilintide Suppresses appetite and enhances satiety buy - image4
Cagrilintide Suppresses appetite and enhances satiety buy - image5
Cagrilintide Suppresses appetite and enhances satiety buy - image6

Cagrilintide Suppresses appetite and enhances satiety

62 Inquiries

Unit Price:

$7-8/G FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ShenZhen

Brand:

No Brand

Packaging:

5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g

Price valid (until):

2026-10-15

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Qualification:
Main Products:

Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    FAQ

    Q1: Can I place a trial order for one vial?
    A: Yes, trial orders are acceptable.

    Q2: What payment terms do you support?
    A: We accept T/T, PayPal, bank transfer and other payment methods. Please pick the one most convenient for you.

    Q3: What is the lead time and shipping option?
    A: We ship by international couriers (DHL, UPS, FedEx) or air freight. Delivery time to your address is approximately 8‑10 business days.


    whatsapp:+852 56087991

    Shop Semaglutide peptide Promotes insulin secretion to control blood glucose for type 2 diabetes-Detailed Image 1 Shop Semaglutide peptide Promotes insulin secretion to control blood glucose for type 2 diabetes-Detailed Image 2 Shop Semaglutide peptide Promotes insulin secretion to control blood glucose for type 2 diabetes-Detailed Image 3


    Shop Semaglutide peptide Promotes insulin secretion to control blood glucose for type 2 diabetes-Detailed Image 4
    Shop Semaglutide peptide Promotes insulin secretion to control blood glucose for type 2 diabetes-Detailed Image 5
    •  Ordering Information

      Standard specifications listed in the catalog are available in stock. For special specifications and batch requirements, please contact our sales team to confirm lead time.

    • Batch traceability: Each batch is assigned a unique batch number. Full COA is available, including purity, molecular weight and sequence verification results. 

    • Custom synthesis: We support sequence modifications (acetylation, amidation, fatty acid modification, etc.), fluorescent / biotin labeling, stable isotope labeling and impurity profile control. • Technical support: Technical consultation and literature support are provided, covering reconstitution, storage and experimental protocol design. 

    • Packaging & Shipping: Standard cold‑chain shipping is offered. Aliquot service is available upon lab request to avoid repeated freeze‑thaw cycles. 

    • Customer scope: Products are only supplied to universities, research institutes, hospital laboratories and biomedical enterprises with R&D qualifications.

    • Quality assurance: All products undergo strict quality testing before delivery. Any quality complaints supported by valid test data will be handled promptly.  Order adjustment: Notify our sales team at least 3 working days in advance if you need to modify or cancel confirmed orders. Changes after shipment cannot be accepted.

    • Payment terms: Multiple payment options are available for qualified customers. Extended credit terms can be discussed based on long-term cooperation. 

    • Confidentiality: Custom synthesis projects and your research information will be kept strictly confidential and will not be disclosed to any third parties.

    • After-sales service: Our technical team remains accessible after delivery to solve problems encountered during sample preparation and experiments.

     Product Name Retatrutide Powder
    Name Retatrutide
    Type Lyophilized Powder
    storage Store in a cool and dark place
    CAS No 2381089-83-2 
    Purity ≥99%
    Specific 5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g
    Package 10 vials/box

    Product Features

    • High Purity: Manufactured by solid-phase peptide synthesis. HPLC purity ≥99%. Each batch is fully tested and verified.
    • Complete Batch Traceability: Every lot is assigned a unique batch number. Full COA documents are provided, including HPLC purity report, mass spectrometry molecular weight identification and sequence verification data.
    • Reliable Peptide Modification: Optimized fatty acid side-chain modification extends the half-life, supporting research on long-acting metabolic regulation.
    • Research Use Only: This product is strictly for laboratory research purposes, not for human or animal clinical treatment.
    • Mechanism of Action

      Retatrutide activates three key metabolic receptors simultaneously. It suppresses appetite and reduces food intake via GLP‑1 and GIP pathways, while GCGR activation elevates energy consumption. The combined triple-pathway effect delivers superior weight-lowering and glucose-controlling effects compared with dual receptor agonists. Its regulatory mode mimics the body’s natural metabolic hormone balance. In clinical research, gastrointestinal reactions are common adverse responses. The safety profile needs to be evaluated according to research data.

      Research Application

      Suitable for in vitro cell assays, in vivo animal model studies, mechanism exploration of obesity, type 2 diabetes, lipid disorders and related metabolic disorders. Widely used in university labs, research institutes, hospital research centers and biomedical R&D enterprises.

      Specifications & Packaging

      • Item: Retatrutide
      • Available strength: 10mg/vial (custom concentrations and packaging available)
      • Form: Lyophilized powder
      • Storage: Long-term storage at -20℃, avoid repeated freeze-thaw.
      • Shipping: Cold chain transportation. Aliquot service is available upon request to prevent sample degradation caused by multiple freeze-thaw cycles.


    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

    Location:

    18 Linchang, Wujin district, Changzhou, China

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

    Company Profile

    HANGZHOU PLANOVO BIOTECH CO LTD. was officially established on August 25, 2016, at Linchang Group, Mandun Village, Jiaze Town, Wujin District, Changzhou, Jiangsu Province, China. As an innovative enterprise dedicated to the biotechnology sector, the company has quickly made its mark in the industry through outstanding R&D capabilities, rigorous quality control, and a diversified business portfolio, guided by its corporate philosophy of "Quality First, Customer Supreme, Innovation-driven, Integrity in Service."

    Business Scope

    The company's business covers a wide range of areas:

    • Biotechnology and Medical Device R&D Consulting: Focusing on frontier biotechnology research and driving the translation of scientific achievements into practical applications;

    • Cosmetics Production and Sales: Offering high-quality cosmetic products built on a mature R&D and manufacturing system;

    • Medical Device Manufacturing and Sales: Covering Class I, Class II, and Class III medical devices, strictly in accordance with the approved scope of relevant licenses.

    R&D Strength

    The company has an R&D team composed of senior researchers and professional technical talents who uphold the spirit of innovation and focus on R&D and consulting services in biotechnology and medical device technology. The team continuously explores cutting-edge technologies, dedicated to converting the latest scientific research results into practical applications and providing a steady stream of momentum for product innovation.

    Main Product: Tirzepatide/Retatrutide/Semaglutide/CBL-514/Peptide/GLP-1/GHK-CU/NAD+

  • Inquiry History
    62 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Hongkong, China

    Cagrilintide

    100 MG Apr 22, 2026
    United Kingdom

    Cagrilintide

    1 KG Apr 14, 2026
    Ireland

    Cagrilintide

    10 PCS Apr 14, 2026
    United States

    Cargrilintide

    10 MG Mar 19, 2026
    United Kingdom

    cagrilintide

    10 MG Feb 18, 2026
    China

    CagriSema cagrilintide 2.5mg+Samaglutide2.5mg

    10 MG Jan 26, 2026
    South Korea

    Cagrilintide

    500 MG Jan 21, 2026
    Pakistan

    cagrilintide

    1 KG Dec 26, 2025
    United States

    Cagrilintide

    20 MG Dec 19, 2025
    United Kingdom

    Cagrilintide

    100 MG Dec 10, 2025
    Canada

    All peptides

    1001 MT Nov 12, 2025
    United States

    Cagrilintide

    10 MG Oct 13, 2024
    United States

    Cagrilintide

    1 MG Jun 3, 2024
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.